Smile-Link Healthcare Global Bhd (XKLS:03023) Stock Based Compensation: RM0.00 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Smile-Link Healthcare Global Bhd Stock Based Compensation?

Smile-Link Healthcare Global Bhd XKLS:03023 Stock Based Compensation is RM0.00 Mil as of Dec. 2025. The stock has 6 warning signs investors should review.

Smile-Link Healthcare Global Bhd's Stock Based Compensation for the six months ended in Dec. 2025 was RM0.00 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2025 was RM0.00 Mil.

Smile-Link Healthcare Global Bhd Stock Based Compensation Related Terms

Smile-Link Healthcare Global Bhd Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Smile-Link Healthcare Global Bhd's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Smile-Link Healthcare Global Bhd Stock Based Compensation Chart

Smile-Link Healthcare Global Bhd Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Jun25
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

Smile-Link Healthcare Global Bhd Semi-Annual Data
Dec16 Dec17 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Smile-Link Healthcare Global Bhd Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was RM0.00 Mil.

What does a Stock Based Compensation of RM0.00 Mil mean?
Smile-Link Healthcare Global Bhd (XKLS:03023) has a Stock Based Compensation of RM0.00 Mil as of Dec. 2025. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Smile-Link Healthcare Global Bhd and its competitors.
Is Smile-Link Healthcare Global Bhd's Stock Based Compensation too high?
Smile-Link Healthcare Global Bhd's current Stock Based Compensation is RM0.00 Mil.
How does Smile-Link Healthcare Global Bhd's Stock Based Compensation compare to HCA and THC?
Smile-Link Healthcare Global Bhd's Stock Based Compensation of RM0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Healthcare Providers & Services company?
A good Stock Based Compensation depends on the Healthcare Providers & Services industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Smile-Link Healthcare Global Bhd and its competitors. Smile-Link Healthcare Global Bhd's current Stock Based Compensation is RM0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Smile-Link Healthcare Global Bhd stock overvalued right now?
Smile-Link Healthcare Global Bhd (XKLS:03023) has a current Stock Based Compensation of RM0.00 Mil. The stock's GF Value™ is RM0.10, compared to a current price of RM0.10 — trading right at its estimated fair value. The current Stock Based Compensation is RM0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Smile-Link Healthcare Global Bhd (XKLS:03023), the current Stock Based Compensation is RM0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Smile-Link Healthcare Global Bhd Business Description

Address Jalan Merah Caga, Lot PT 7221, Taman Sri Endah, Bandar Baru Sri Petaling, Kuala Lumpur, MYS, 57000
Smile-Link Healthcare Global Bhd through its subsidiaries, is engaged in providing dental healthcare services in Malaysia. Its reportable operating segments are; Provision of dental services which derives maximum revenue, Trading and distribution of dental and pharmaceutical products, Others, comprising dental labs and manufacturing of dental instruments, and Investment holding.